Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
26-28 August, 2025
KY/TN Water Profession...KY/TN Water Professionals
Not Confirmed
Not Confirmed
27-30 July, 2025
Chemicals AmericaChemicals America
Not Confirmed
Not Confirmed
29-31 July, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
26-28 August, 2025
KY/TN Water Profession...KY/TN Water Professionals
Industry Trade Show
Not Confirmed
27-30 July, 2025
Chemicals AmericaChemicals America
Industry Trade Show
Not Confirmed
29-31 July, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-veranova-carbogen-lead-adc-investments-axplora-polfa-tarchomin-famar-expand-european-footprint
04 Jun 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/06/04/3093431/0/en/Design-Therapeutics-Announces-Start-of-Friedreich-Ataxia-Patient-Dosing-Ex-U-S-in-its-RESTORE-FA-Phase-1-2-Multiple-Ascending-Dose-Trial-of-DT-216P2.html
28 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/28/3089410/0/en/Design-Therapeutics-to-Participate-in-2025-Jefferies-Global-Healthcare-Conference.html
13 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/13/3080042/0/en/Design-Therapeutics-to-Participate-in-2025-RBC-Capital-Markets-Healthcare-Conference.html
07 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/07/3076525/0/en/Design-Therapeutics-Highlights-Momentum-Across-Lead-GeneTAC-Programs-and-Reports-First-Quarter-2025-Financial-Results.html
01 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/01/3072316/0/en/Design-Therapeutics-Announces-Favorable-Phase-1-Data-for-DT-168-Supporting-Advancement-into-Phase-2-Biomarker-Trial-for-Patients-with-Fuchs-Endothelial-Corneal-Dystrophy.html
21 Apr 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/04/21/3064963/0/en/Design-Therapeutics-to-Present-Phase-1-Data-for-Fuchs-Endothelial-Corneal-Dystrophy-Program-at-Eyecelerator-Park-City-2025.html
ABOUT THIS PAGE